Exhibit 1 to “Pharmacological Activities of the Main Metabolite of Flavoxate 3-Methylflavone-8-carboxylic Acid”, Arzenmittel-Forschung, P. Cazzulani et al., pp 379-382, 1988. |
Flavio Trigo-Roche et al., Am. J. Physiol, Feb. 1992, 264, H419-H422. |
Allenby et al., Angiology, vol. 42(5), 1991, p. 418-420. |
Nicholson et al., Trends in Pharmaceutical Sciences, vol. 12, Jan. 1991, p. 19-27. |
Rote Liste 1992—Trental. |
Physician's Desk Reference 1992—Trental®. |
Beavo et al., Trends in Pharmaceutical Sciences, Apr., 1990, p. 150-155. |
Trigo-Rocha et al., Neurology and Urodynamics, 1994, vol. 13, p. 71-80. |
J. Urol., Trigo-Rocha, V. 149, 872-877, 1993. |
ABPI Data Sheet Compendium, 1990-1991; pp. 740-742. |
Rote Liste 1992, (along with English translation). |
Medicinal and Poisonous Plants in Southwest Africa, Ebrhard von Koenen, 1979 (along with English translation). |
Pharmacological Expert Opinion on the Use of cGMP Inhibitors for the Oral Treatment of Erectile Dysfunction in Men, Professor J. C. Frolich, Exhibit 2, (along with english translation) Dec. 10, 1998. |
Journal of Japanese Society of Urology, Oct. 1992, vol. 83, No. 1, pp. 1655-1661, Yasuo Kawanishi, et al. Abstract. |
Optimizing Therapy with Methylxanthines, Ekkehard Haen, et al., Aug. 1989 (along with English translation); C1435-C1440. |
Hagers Handbuch Der Pharmazeutischen Praxis, begonnen Von W. Kern, et al., 1971, p. 675-676 (along with English translation). |
Br. J. Pharmacol. 1992, 106, 1028-1034, Jacob de Boer, et al. |
The Journal of Urology, vol. 149, Apr. 1993, No. 4, AUA Eighty-Eighth Annual Meeting May 15-20, Abstract 285. |
Physician's Desk Reference, 1992, 46th Edition, pp. 1099-1100. |
Trends in Pharmacological Sciences, Jan. 1991, vol. 12, No. 1, C. David Nicholson, et al., pp. 19-24. |
CNN—Viagra?, Jun. 19, 1998. |
Pharmac. Ther. vol. 51, pp. 13-33, 1991, W. Joseph Thompson. |
Aronson et al, J. Urol. 147 Supp 454A, 1992, No. 967. |
International Journal of Impotence Research, vol. 6, No. 1, Mar. 1994, A. W. Zorgniotti, et al, pp. 33-36. |
Postgraduate Medicine, Treatment alternatives for impotence, E. Douglas Whitehead, et al, pp. 139-145. |
Drug Therapy, Aug. 1989, Treating Erectile Dysfunction, I.J. Fishman, pp. 102-111. |
Molecular Pharmacology, vol. 36, No. 5, Nov. 1989, Peter G. Gillespie, and Joseph A. Beavo, pp. 773-781. |
J. Mol. Cell Cardiol, 1980, 12/10 (939-954), Abstract. |
Postgraduate Medicine, vol. 93, No. 3, Management of Impotence, John E. Morley, pp. 65-72. |
Biochemical Pharmacology, vol. 46, No. 5, pp. 833-839, 1993, T. Saeki et al. |
Tohoku J. Exp. Med., 1991, 165, Yoshlastu Takahashi, et al, pp. 49-58. |
Br. J. Dis. Chest, 1986, 80, J. Riser, et al, pp. 157-163. |
Journal of Medicine, vol. 10, No. 6, 1979, J.L. Ambrus, et al, pp. 445-456. |
Br. J. Pharmacol., 1993, 108, 562-568, J. Cortijo, et al. |
Journal of Ethnopharmacology, 12, 1984, 36-74, Hans-Joechim Arnold, et al. |
Journal of Pharm. & Exper. Therapeutics, 1989, E. G. McMahon, et al, pp. 1000-1005. |
British Journal of Diseases of the Chest, Robin M. Rudd, et al, 1988, 77, pp. 78-86. |
Martindale The Extra Pharmacopoeia, 29th Ed., 1989, p. 1423, heading 14026-m. |
Archives of Pharmacology, W. R. Kukovetz, Evidence for Cyclic GMP-Mediated Relaxant Effects of Nitro-Compounds in Coronary Smooth Muscle, 1979, 131-137. |
Journal of the American Geriatrics Society, vol. 41, No. 4, 1993, Stanley G. Korenman, et al., p. 363-366. |
Clin. Res., vol. 36(1), 123(A), Korenmann SG, Treatment of Vasculogema Sexual Dysfunction with pentoxyfylline, 1988. |
American Physiological Society, Joseph A. Beavo, Cyclic Nucleotide Phosphodiesterases: Functional Implications of Multiple Isoforms, pp. 725-748, 1995. |
Drug Res., Pharmacological Activities of the Main Metabolite of Flavoxate 3-Methylflavone-8-carboxylic Acid, Arzenmittel-Forschung, P. Cazzulani, et al, pp. 379-382 38(1) 1988. |
The Journal of urology, vol. 145, No. 4, 1991, AUA Eighty-sixth Annual Meeting Jun. 2-6, 1991, p. 341A, Abstract 516. |
Excerpts from the UCLA doctoral dissertation of Margaret Ann Bush, including pp. ii-xvii, 1 and 154-161, 1993. |
Karl-Erik Anderson et al. The American Physiological Society, 1995, vol. 75, pp. 191-236. |
W. Meinhardt et al., International Journal of Impotence Research, 1997, vol. 9, pp. 17-26. |
F. Holmquist et al., Arta Physil Scand, 1991, vol. 143, pp. 299-304. |
M. F. Meyer et al., Ann Urol., 1993, vol. 27, No. 3, pp. 179-182. |
Y.-M. Lin et al., Urol. Res, 1990, vol. 24., pp. 27-32. |
Bowman et al., Br. J. Pharmacol. 81, 665-674, 1984. |
Murray, DN&P, 6, 1993, 150-156. |
Rajfer et al., NEJ Med. 326, 90-94, 1992. |
Bush et al., J. Urol., 147, 1650-1655, 1992. |
Harvey C. Taub, et al., Urology, 1993, vol. 42, No. 6, pp. 698-704. |
Taher et al., Int. J. Impotence Res., 1992 vol. 4, Suppl. 2, p. 11. |
Rongshhi Li, et al., Abstracts of Papers American Chemical Society 210, (1-2), 1995, “210th Am. Chem. Society National Meeting, Chicago, IL, Aug. 20-24, 1995” (Abstract 229). |